Ποια είναι η τιμή για China Jo-Jo Drugstores, Inc. (CJJD)

Η τιμή για China Jo-Jo Drugstores, Inc. (CJJD) είναι $1.05

Ποια είναι η κεφαλαιοποίηση αγοράς για China Jo-Jo Drugstores, Inc. (CJJD)

Η κεφαλαιοποίηση αγοράς για China Jo-Jo Drugstores, Inc. (CJJD) είναι $114.95K

China Jo-Jo Drugstores, Inc. (CJJD) Λειτουργικό Περιθώριο

China Jo-Jo Drugstores, Inc., along with its subsidiary entities, functions as a prominent retailer and distributor of a wide array of pharmaceutical and healthcare products across the People's Republic of China. Its operations are structured into four distinct segments: retail pharmacies, an online drugstore, wholesale drug distribution, and the cultivation of medicinal herbs. The company's brick-and-mortar stores supply customers with diverse pharmaceutical items, including both prescription and over-the-counter medications, nutritional supplements, traditional Chinese remedies, personal and family care products, and medical devices. Beyond these, they also stock everyday convenience goods such as consumables, seasonal items, and promotional merchandise. To further enhance customer service, these locations feature licensed practitioners of both Western and Traditional Chinese Medicine, available at scheduled times for consultations, examinations, and the treatment of common ailments. Additionally, China Jo-Jo Drugstores operates an internet-based pharmacy, marketing over-the-counter medications and health supplements directly to consumers, as well as leveraging third-party e-commerce platforms for sales. The enterprise also engages in the wholesale supply of third-party pharmaceutical goods, primarily to trading companies, and manages the cultivation and distribution of herbs utilized in Traditional Chinese Medicine. As of March 31, 2021, the company maintained a network of 109 retail pharmacies operating under the 'Jiuzhou Grand Pharmacy' brand, supplemented by four other drugstores. Founded in 2003, the firm's corporate headquarters are situated in Hangzhou, People's Republic of China.

Έτος	Λειτουργικό Περιθώριο	Αλλαγή
2026 (TTM)	1.13%	-231.40%
2025	-0.86%	-62.45%
2024	-2.29%	-83.71%
2023	-14.06%	757.32%
2022	-1.64%	-75.30%
2021	-6.64%	11.22%
2020	-5.97%	637.04%
2019	-0.81%	-95.68%
2018	-18.75%	150.67%
2017	-7.48%	24,833.33%
2016	-0.03%	-101.35%
2015	2.22%	-107.64%
2014	-29.07%	106.76%
2013	-14.06%	-226.55%
2012	11.11%	-167.13%
2011	-16.55%	-171.58%
2010	23.12%	0.00%
2008	0.00%	0.00%
2007	0.00%	0.00%

Έτος

Λειτουργικό Περιθώριο

Αλλαγή

2026 (TTM)

1.13%

-231.40%

2025

-0.86%

-62.45%

2024

-2.29%

-83.71%

2023

-14.06%

757.32%

2022

-1.64%

-75.30%

2021

-6.64%

11.22%

2020

-5.97%

637.04%

2019

-0.81%

-95.68%

2018

-18.75%

150.67%

2017

-7.48%

24,833.33%

2016

-0.03%

-101.35%

2015

2.22%

-107.64%

2014

-29.07%

106.76%

2013

-14.06%

-226.55%

2012

11.11%

-167.13%

2011

-16.55%

-171.58%

2010

23.12%

0.00%

2008

0.00%

2007

0.00%

Εταιρεία	Λειτουργικό Περιθώριο	Διαφορά Λειτουργικού Περιθωρίου	Χώρα
Royalty Pharma plc RPRX.US	67.93%	-39.88%	US
Swedish Orphan Biovitrum AB SOBI.ST	0.00%	-	SE
Ipsen S.A. IPN.PA	0.00%	-	FR
Recordati Industria Chimica e Farmaceutica S.p.A. REC.MI	0.00%	-	IT
Corcept Therapeutics Incorporated CORT.US	0.77%	-99.32%	US

Εταιρεία

Λειτουργικό Περιθώριο

Διαφορά Λειτουργικού Περιθωρίου

Χώρα